The mechanisms of cancer-associated thrombosis

Thrombosis Research

Volumn 135, Issue S1, 2015, Pages S8-S11

  Falanga, Anna ^a   Marchetti, Marina ^a   Russo, Laura ^a  

^a PAPA GIOVANNI XXIII HOSPITAL   (Italy)

Author keywords

Cancer; Hemorrhage; Hypercoagulable state; Thrombosis; Tissue factor

Indexed keywords

BIOLOGICAL FACTOR; CYTOKINE;

ARTICLE; BLOOD CLOTTING DISORDER; CANCER PATIENT; HEMOSTASIS; HUMAN; MORBIDITY; MORTALITY; PATHOGENESIS; PRIORITY JOURNAL; RISK ASSESSMENT; TUMOR THROMBUS; VENOUS THROMBOEMBOLISM; BIOLOGICAL MODEL; BLOOD CLOTTING; IMMUNOLOGY; NEOPLASM; NEUTROPHIL; PATHOLOGY; THROMBOCYTE; THROMBOSIS;

BLOOD COAGULATION; BLOOD PLATELETS; CYTOKINES; HUMANS; MODELS, CARDIOVASCULAR; MODELS, IMMUNOLOGICAL; NEOPLASMS; NEUTROPHILS; THROMBOSIS;

EID: 84923013320     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/S0049-3848(15)50432-5     Document Type: Article

References (25)

1. A. Falanga, and L. Russo Epidemiology, risk and outcomes of venous thromboembolism in cancer Hamostaseologie 32 2 2012 115 125
2. N. Magnus, E. D'Asti, B. Meehan, D. Garnier, and J. Rak Oncogenes and the coagulation system - forces that modulate dormant and aggressive states in cancer Thromb Res 133 Suppl 2 2014 S1 S9
3. J.F. Timp Epidemiology of cancer-associated venous thrombosis Blood 122 10 2013 1712 1723
4. D. Farge International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer J Thromb Haemost 11 1 2013 56 70
5. G.H. Lyman Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update J Clin Oncol 31 17 2013 2189 2204
6. A. Falanga, L. Russo, and C. Verzeroli Mechanisms of thrombosis in cancer Thromb Res 131 Suppl 1 2013 S59 S62
7. A.A. Khorana, and K.R. McCrae Risk stratification strategies for cancer-associated thrombosis: an update Tromb Res 133 S2 2014 S35 S38
8. A. Falanga, M. Marchetti, and A. Vignoli Coagulation and cancer: biological and clinical aspects J Thromb Haemost 11 2 2013 223 233
9. Y. Nadir, and B. Brenner Heparanase multiple effects in cancer Thromb Res 133 Suppl 2 2014 S90 S94
10. A. Falanga, C.J. Tartari, and M. Marchetti Microparticles in tumor progression Thromb Res 129 Suppl 1 2012 S132 S136
11. N. Magnus Tissue factor expression provokes escape from tumor dormancy and leads to genomic alterations Proc Natl Acad Sci U S A 111 9 2014 3544 3549
12. D. Stegner, S. Dutting, and B. Nieswandt Mechanistic explanation for platelet contribution to cancer metastasis Thromb Res 133 Suppl 2 2014 S149 S157
13. M. Demers, and D.D. Wagner Neutrophil extracellular traps: A new link to cancer-associated thrombosis and potential implications for tumor progression Oncoimmunology 2 2 2013 e22946
14. I. Pabinger, J. Thaler, and C. Ay Biomarkers for prediction of venous thromboembolism in cancer Blood 122 12 2013 2011 2018
15. C. Ay High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS) Blood 112 7 2008 2703 2708
16. C. Ay D-dimer and prothrombin fragment 1 + 2 predict venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study J Clin Oncol 27 25 2009 4124 4129
17. J.I. Zwicker Prediction and prevention of thromboembolic events with enoxaparin in cancer patients with elevated tissue factor-bearing microparticles: a randomized-controlled phase II trial (the Microtec study) Br J Haematol 160 4 2013 530 537
18. C. Ay Prediction of venous thromboembolism in patients with cancer by measuring thrombin generation: results from the Vienna Cancer and Thrombosis Study J Clin Oncol 29 15 2011 2099 2103
19. A.A. Khorana Development and validation of a predictive model for chemotherapy-associated thrombosis Blood 111 10 2008 4902 4907
20. M. Verso A modified Khorana risk assessment score for venous thromboembolism in cancer patients receiving chemotherapy: the Protecht score Intern Emerg Med 7 3 2012 291 292
21. A. Palumbo Prevention of thalidomide-and lenalidomide-associated thrombosis in myeloma Leukemia 22 2 2008 414 423
22. M.L. Louzada Development of a clinical prediction rule for risk stratification of recurrent venous thromboembolism in patients with cancer-associated venous thromboembolism Circulation 126 4 2012 448 454
23. P.L. den Exter, J. Kooiman, and M.V. Huisman Validation of the Ottawa prognostic score for the prediction of recurrent venous thromboembolism in patients with cancer-associated thrombosis J Thromb Haemost 11 5 2013 998 1000
24. A. Di Castelnuovo Association of D-dimer levels with all-cause mortality in a healthy adult population: findings from the MOLI-SANI study Haematologica 98 9 2013 1476 1480
25. A. Amirkhosravi Blood clotting activation analysis for preoperative differentiation of benign versus malignant ovarian masses Blood Coagul Fibrinolysis 24 5 2013 510 517